Last reviewed · How we verify
nonsteroidal anti-inflammatory drug
nonsteroidal anti-inflammatory drug is a Small molecule drug developed by LG Chem. It is currently in Phase 1 development. Also known as: Naproxen.
At a glance
| Generic name | nonsteroidal anti-inflammatory drug |
|---|---|
| Also known as | Naproxen |
| Sponsor | LG Chem |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Arthralgia
- Urinary tract infection
- Upper respiratory tract infection
- Headache
- Nasopharyngitis
- Back pain
- Bronchitis
- Hypertension
- Herpes zoster
- Cough
- Rheumatoid arthritis
- Blood creatine phosphokinase increased
Key clinical trials
- Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis (NA)
- Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis (PHASE4)
- Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older
- Ear Pressure Points Plus Pain Meds for Faster Kidney Stone Pain Relief (NA)
- Does the Development of the Repeated Bout Effect Depend on Oxidative Stress and Inflammation? (NA)
- Metformin Safety and Efficacy in Osteoarthritis. (PHASE3)
- FRONT Block for Quality of Recovery After Total Hip Arthroplasty (NA)
- Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- nonsteroidal anti-inflammatory drug CI brief — competitive landscape report
- nonsteroidal anti-inflammatory drug updates RSS · CI watch RSS
- LG Chem portfolio CI
Frequently asked questions about nonsteroidal anti-inflammatory drug
What is nonsteroidal anti-inflammatory drug?
nonsteroidal anti-inflammatory drug is a Small molecule drug developed by LG Chem.
Who makes nonsteroidal anti-inflammatory drug?
nonsteroidal anti-inflammatory drug is developed by LG Chem (see full LG Chem pipeline at /company/lg-chem).
Is nonsteroidal anti-inflammatory drug also known as anything else?
nonsteroidal anti-inflammatory drug is also known as Naproxen.
What development phase is nonsteroidal anti-inflammatory drug in?
nonsteroidal anti-inflammatory drug is in Phase 1.
What are the side effects of nonsteroidal anti-inflammatory drug?
Common side effects of nonsteroidal anti-inflammatory drug include Arthralgia, Urinary tract infection, Upper respiratory tract infection, Headache, Nasopharyngitis, Back pain.
Related
- Manufacturer: LG Chem — full pipeline
- Also known as: Naproxen
- Compare: nonsteroidal anti-inflammatory drug vs similar drugs
- Pricing: nonsteroidal anti-inflammatory drug cost, discount & access